Source - LSE Regulatory
RNS Number : 7183O
Dr. Martens PLC
14 June 2022
 

Dr. Martens plc (the "Company")

2022 Annual Report and Notice of Annual General Meeting

Further to the announcement of its preliminary results for the financial year ended 31 March 2022 and in accordance with Listing Rule 9.6.1, the Company announces that the following documents have been submitted in full unedited text to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism:

·      Annual Report and Accounts for the financial year ended 31 March 2022 (the "2022 Annual Report")

·      Notice of the 2022 Annual General Meeting (the "2022 Notice of Meeting"), which will take place at 9.30am on Thursday 14 July 2022 at 28 Jamestown Road, Camden, London, NW1 7BY

·      Form of Proxy for the 2022 Annual General Meeting

In compliance with rule 6.3.5R of the Disclosure Guidance and Transparency Rules, the 2022 Annual Report and 2022 Notice of Meeting are also available on the Company's website, www.drmartensplc.com. The 2022 Annual Report and Financial Statements have been prepared using the single electronic reporting format specified in the TD ESEF Regulation.

Emily Reichwald
General Counsel and Company Secretary
14 June 2022

 

ENDS

 

About Dr. Martens plc:

 

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude.  

 

The Company successfully listed on the main market of the London Stock Exchange in January 2021 (DOCS.L) and is a constituent of the FTSE 250 index. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSGPUMPQUPPGMW
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.